XML 46 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Equity and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Activity and Total Number of Shares Available for Grant

The following table presents the stock activity and the total number of shares available for grant as of December 31, 2024:

 

 

 

(in thousands)

 

Balance at December 31, 2023

 

 

1,059

 

Options cancelled

 

 

7

 

Restricted stock granted

 

 

(214

)

Forfeited/ Expired restricted stock added back

 

 

46

 

Performance-Based restricted stock unearned

 

 

1

 

Performance-Based restricted stock granted

 

 

(171

)

Balance at December 31, 2024

 

 

728

 

Stock-based Compensation Expense

Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company's stock-based units, was comprised as follows:

 

 

 

Year ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Cost of revenue

 

$

727

 

 

$

824

 

 

$

433

 

Selling and marketing

 

 

1,928

 

 

 

2,475

 

 

 

2,028

 

Research and development

 

 

1,532

 

 

 

1,870

 

 

 

1,444

 

General and administrative

 

 

1,985

 

 

 

6,814

 

 

 

4,079

 

Total stock-based compensation

 

$

6,172

 

 

$

11,983

 

 

$

7,984

 

Stock Option Activity

 

 

Options Outstanding

 

 

 

Number of
Shares
Underlying
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding at December 31, 2023

 

 

1,041,452

 

 

$

9.10

 

 

 

4.22

 

 

$

3,137,285

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Exercised

 

 

(396,213

)

 

 

8.28

 

 

 

 

 

 

 

Forfeited

 

 

(7,323

)

 

 

28.99

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

637,916

 

 

$

9.38

 

 

 

4.55

 

 

$

5,483,767

 

Vested and expected to vest at December 31, 2024

 

 

639,616

 

 

$

9.46

 

 

 

4.55

 

 

$

5,483,767

 

Exercisable at December 31, 2024

 

 

637,780

 

 

$

9.46

 

 

 

4.55

 

 

$

5,483,767

 

Restricted Stock Awards  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted Stock Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Nonvested restricted stock at December 31, 2023

 

 

764,942

 

 

$

14.76

 

Granted

 

 

213,673

 

 

 

17.02

 

Vested

 

 

(327,478

)

 

 

14.20

 

Shares forfeited

 

 

(45,781

)

 

 

13.87

 

Nonvested restricted stock at December 31, 2024

 

 

605,356

 

 

$

15.92